Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already ...

Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...

I’m 63 and have been diagnosed with atrial fibrillation. I wonder what you know about medical care and self-care for the ...

The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.